Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 studyArmando Santoro, Camillo Porta, Stefania Salvagni et al.|The Lancet Oncology|2012Cited by 550
Tirapazamine Plus Cisplatin Versus Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Report of the International CATAPULT I Study GroupJoachim von Pawel, Joseph Treat, Reinhard von Roemeling et al.|Journal of Clinical Oncology|2000Cited by 286